MAIA Biotechnology, Inc. (MAIA)

NYSEAMERICAN: MAIA · IEX Real-Time Price · USD
4.97
-0.08 (-1.58%)
Aug 12, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Selling, General & Admin
4.295.56
Research & Development
3.51.41
Operating Expenses
7.796.98
Operating Income
-7.79-6.98
Interest Expense / Income
0.830.03
Other Expense / Income
3.89-0.37
Pretax Income
-12.5-6.64
Net Income
-12.5-6.64
Net Income Common
-12.5-6.64
Shares Outstanding (Basic)
54
Shares Outstanding (Diluted)
54
Shares Change
19.23%-
EPS (Basic)
-2.37-1.50
EPS (Diluted)
-2.37-1.50
Free Cash Flow Per Share
-0.78-0.42
EBITDA
-11.68-6.6
EBIT
-11.68-6.6
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).